Serological response of leprosy patients to Mycobacterium leprae specific and mycobacteria specific antigens: possibility of using these assays in combinations.

The serological response of 147 leprosy patients to 3 mycobacterial antigens, PGL-I, 35 kDa (Mycobacterium leprae-specific) and LAM (which is a common mycobacterial antigen) were analysed. A stronger serological response was seen amongst the MB patients than the PB patients in all the assays. The 3 antibody levels correlated positively with each other in both MB and PB cases. An overlap of seropositivity was seen between anti-PGL-I and anti-LAM (p > 0.05). A progressive increase in seropositivity and a significant difference of absorbance or titre in antibody levels in all 3 assays over increasing grades of BI were seen in the MB patients (p < 0.05). A significant difference in seropositivity between untreated and treated groups of patients was observed for anti PGL-I (p < 0.05) and antiLAM (p < 0.01) antibodies. The sensitivity, specificity and efficiency of antiPGL-I (50%; 99%; 70%), antiLAM (43%; 95%; 64%) and anti35 kDa (66%; 100%; 80%) assays taken individually were less than that of combinations of antiPGL-I/anti-35 kDa (74%; 99%; 84%) or antiPGL-I/anti-35 kDa/antiLAM (80%; 94%; 86%). The difference in the efficiency of both sets of combination of assays were not statistically significant (p > 0.05).

[1]  K. Katoch,et al.  Association of mycobacterial-specific and Mycobacterium leprae specific antibody levels with clinical activity in tuberculoid leprosy: a comparative study of three serological enzyme-immunoassays. , 1991, Leprosy review.

[2]  A. Wakamatsu,et al.  Indeterminate leprosy: histopathologic and histochemical predictive parameters involved in its possible change to paucibacillary or multibacillary leprosy. , 1991, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[3]  B. K. Girdhar,et al.  On the value of sequential serology with a Mycobacterium leprae-specific antibody competition ELISA in monitoring leprosy chemotherapy. , 1991, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[4]  H. Ludwig,et al.  Heterogeneity of serological responses in paucibacillary leprosy--differential responses to protein and carbohydrate antigens and correlation with clinical parameters. , 1990, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[5]  P. Klatser,et al.  Evaluation of Mycobacterium leprae antigens in the monitoring of a dapsone-based chemotherapy of previously untreated lepromatous patients in Cebu, Philippines. , 1989, Leprosy review.

[6]  B. Vasanthi,et al.  Use of eluates of filter paper blood spots in ELISA for the serodiagnosis of leprosy. , 1989, The Indian journal of medical research.

[7]  J. Ivanyi,et al.  A comparative evaluation of serological assays for lepromatous leprosy. , 1988, Leprosy review.

[8]  N. Lyons,et al.  Association of IgG and IgM antibodies to phenolic glycolipid-1 antigen of Mycobacterium leprae with disease parameters in multibacillary leprosy patients. , 1988, Leprosy review.

[9]  P. Brennan,et al.  Mycobacterial carbohydrate antigens for serological testing of patients with leprosy. , 1987, The Journal of infectious diseases.

[10]  P. Brennan,et al.  ELISA detection of IgM antibodies against phenolic glycolipid-I in the management of leprosy: a comparison between laboratories. , 1986, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[11]  B. Flageul,et al.  Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy. , 1986, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[12]  A. Basten,et al.  Mycobacterium leprae antigens involved in human immune responses. I. Identification of four antigens by monoclonal antibodies. , 1985, Journal of immunology.

[13]  A. Kolk,et al.  An ELISA-inhibition test using monoclonal antibody for the serology of leprosy. , 1985, Clinical and experimental immunology.

[14]  J. Ivanyi,et al.  Serological survey of leprosy and control subjects by a monoclonal antibody-based immunoassay. , 1985, International journal of leprosy and other mycobacterial diseases.

[15]  D. Young,et al.  A serological test for leprosy with a glycolipid specific for Mycobacterium leprae. , 1983, Science.

[16]  M. Harboe,et al.  Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) leprosy. , 1983, International journal of leprosy and other mycobacterial diseases.

[17]  P. Brennan,et al.  Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy , 1983, Infection and immunity.

[18]  R. Miller,et al.  Development of an enzyme-linked immunosorbent assay using arabinomannan from Mycobacterium smegmatis: a potentially useful screening test for the diagnosis of incubating leprosy. , 1983, The American journal of tropical medicine and hygiene.

[19]  R. Rees,et al.  Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis. , 1983, Clinical and experimental immunology.

[20]  M. Harboe,et al.  Demonstration of antibodies reacting with different determinants on Mycobacterium leprae antigen 7. , 1981, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.